

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.52874853 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.52874853 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.34792548 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34792548 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.89716371 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78606812 |
| 7 | serine family amino acid catabolic process (GO:0009071) | 5.66272286 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.57844234 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 5.54516495 |
| 10 | cysteine metabolic process (GO:0006534) | 5.44097659 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42404944 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.32333099 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.32333099 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.32333099 |
| 15 | amino-acid betaine metabolic process (GO:0006577) | 5.29047545 |
| 16 | uronic acid metabolic process (GO:0006063) | 5.21017669 |
| 17 | glucuronate metabolic process (GO:0019585) | 5.21017669 |
| 18 | kynurenine metabolic process (GO:0070189) | 5.19345100 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.06028930 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.05458936 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.00331478 |
| 22 | glycine metabolic process (GO:0006544) | 4.94826648 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.90043136 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82691998 |
| 25 | lysine metabolic process (GO:0006553) | 4.81867643 |
| 26 | lysine catabolic process (GO:0006554) | 4.81867643 |
| 27 | homocysteine metabolic process (GO:0050667) | 4.81127635 |
| 28 | serine family amino acid metabolic process (GO:0009069) | 4.72176959 |
| 29 | urea cycle (GO:0000050) | 4.67944626 |
| 30 | urea metabolic process (GO:0019627) | 4.67944626 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.67809585 |
| 32 | urate metabolic process (GO:0046415) | 4.63087123 |
| 33 | serine family amino acid biosynthetic process (GO:0009070) | 4.53622226 |
| 34 | negative regulation of sterol transport (GO:0032372) | 4.52318036 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.52318036 |
| 36 | drug catabolic process (GO:0042737) | 4.52218566 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.51699689 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.50526037 |
| 39 | protein carboxylation (GO:0018214) | 4.50526037 |
| 40 | bile acid metabolic process (GO:0008206) | 4.50498052 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.46992199 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.38154013 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.33335138 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 4.33091884 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.32799853 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.31216347 |
| 47 | omega-hydroxylase P450 pathway (GO:0097267) | 4.28215905 |
| 48 | fibrinolysis (GO:0042730) | 4.22427612 |
| 49 | hormone catabolic process (GO:0042447) | 4.20498307 |
| 50 | drug transmembrane transport (GO:0006855) | 4.18546502 |
| 51 | regulation of protein activation cascade (GO:2000257) | 4.16994329 |
| 52 | regulation of fibrinolysis (GO:0051917) | 4.16972442 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 4.16448055 |
| 54 | macromolecular complex remodeling (GO:0034367) | 4.16448055 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.16448055 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.08490521 |
| 57 | tyrosine metabolic process (GO:0006570) | 4.03870275 |
| 58 | phospholipid efflux (GO:0033700) | 4.02907835 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.02641063 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.02641063 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.00293990 |
| 62 | complement activation, alternative pathway (GO:0006957) | 3.98202835 |
| 63 | acute-phase response (GO:0006953) | 3.91623102 |
| 64 | fructose metabolic process (GO:0006000) | 3.91017025 |
| 65 | regulation of complement activation (GO:0030449) | 3.90639525 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.87033792 |
| 67 | carnitine metabolic process (GO:0009437) | 3.84862663 |
| 68 | negative regulation of protein activation cascade (GO:2000258) | 3.84793209 |
| 69 | vitamin transmembrane transport (GO:0035461) | 3.79525717 |
| 70 | biotin metabolic process (GO:0006768) | 3.77096469 |
| 71 | cholesterol efflux (GO:0033344) | 3.76500592 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.75143097 |
| 73 | carboxylic acid catabolic process (GO:0046395) | 3.75025153 |
| 74 | organic acid catabolic process (GO:0016054) | 3.75025153 |
| 75 | folic acid metabolic process (GO:0046655) | 3.74258512 |
| 76 | complement activation (GO:0006956) | 3.74134782 |
| 77 | * pantothenate metabolic process (GO:0015939) | 3.74066930 |
| 78 | alkaloid metabolic process (GO:0009820) | 3.73960637 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.73848929 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.73848929 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 3.73305265 |
| 82 | protein activation cascade (GO:0072376) | 3.73290278 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.73169246 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72040031 |
| 85 | drug transport (GO:0015893) | 3.71952458 |
| 86 | amine catabolic process (GO:0009310) | 3.71830789 |
| 87 | cellular biogenic amine catabolic process (GO:0042402) | 3.71830789 |
| 88 | fatty acid beta-oxidation (GO:0006635) | 3.71385796 |
| 89 | ketone body metabolic process (GO:1902224) | 3.71229731 |
| 90 | heme transport (GO:0015886) | 3.70890848 |
| 91 | drug metabolic process (GO:0017144) | 3.70197078 |
| 92 | cellular glucuronidation (GO:0052695) | 3.70134691 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.69875636 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 3.69359901 |
| 95 | glutamate metabolic process (GO:0006536) | 3.68980171 |
| 96 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.67014149 |
| 97 | fatty acid oxidation (GO:0019395) | 3.65628061 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.64514926 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.63000254 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.62457237 |
| 101 | flavonoid metabolic process (GO:0009812) | 3.61342665 |
| 102 | polyketide metabolic process (GO:0030638) | 3.61039523 |
| 103 | doxorubicin metabolic process (GO:0044598) | 3.61039523 |
| 104 | daunorubicin metabolic process (GO:0044597) | 3.61039523 |
| 105 | lipid oxidation (GO:0034440) | 3.58684278 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.57737779 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56700318 |
| 108 | negative regulation of hemostasis (GO:1900047) | 3.55665466 |
| 109 | negative regulation of blood coagulation (GO:0030195) | 3.55665466 |
| 110 | plasma lipoprotein particle assembly (GO:0034377) | 3.55061551 |
| 111 | L-serine metabolic process (GO:0006563) | 3.54791474 |
| 112 | sterol homeostasis (GO:0055092) | 3.53488097 |
| 113 | phenylpropanoid metabolic process (GO:0009698) | 3.51310343 |
| 114 | monocarboxylic acid catabolic process (GO:0072329) | 3.50903081 |
| 115 | fatty acid catabolic process (GO:0009062) | 3.50899654 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 3.49963540 |
| 117 | arginine metabolic process (GO:0006525) | 3.49949043 |
| 118 | S-adenosylmethionine metabolic process (GO:0046500) | 3.47491453 |
| 119 | detection of other organism (GO:0098543) | 3.47025394 |
| 120 | regulation of humoral immune response (GO:0002920) | 3.45935029 |
| 121 | negative regulation of complement activation (GO:0045916) | 3.45537454 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.41268288 |
| 123 | folic acid transport (GO:0015884) | 3.41174661 |
| 124 | sulfur amino acid metabolic process (GO:0000096) | 3.39285148 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 3.38611341 |
| 126 | opsonization (GO:0008228) | 3.37351004 |
| 127 | negative regulation of coagulation (GO:0050819) | 3.35516924 |
| 128 | detection of bacterium (GO:0016045) | 3.31938001 |
| 129 | ethanol oxidation (GO:0006069) | 3.31613522 |
| 130 | oxidative demethylation (GO:0070989) | 3.29407693 |
| 131 | positive regulation of hemostasis (GO:1900048) | 3.26203241 |
| 132 | positive regulation of blood coagulation (GO:0030194) | 3.26203241 |
| 133 | detection of molecule of bacterial origin (GO:0032490) | 3.25559045 |
| 134 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.24848825 |
| 135 | detection of external biotic stimulus (GO:0098581) | 3.22051855 |
| 136 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.18921648 |
| 137 | negative regulation of wound healing (GO:0061045) | 3.15007771 |
| 138 | positive regulation of coagulation (GO:0050820) | 3.10065755 |
| 139 | * acute inflammatory response (GO:0002526) | 3.09742253 |
| 140 | negative regulation of humoral immune response (GO:0002921) | 3.09138542 |
| 141 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08791653 |
| 142 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08147889 |
| 143 | angiotensin maturation (GO:0002003) | 3.03024117 |
| 144 | macrophage activation involved in immune response (GO:0002281) | 3.02251999 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95853559 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.90334460 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90334460 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.90334460 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90334460 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90334460 |
| 151 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90334460 |
| 152 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82864638 |
| 153 | primary alcohol catabolic process (GO:0034310) | 2.82412603 |
| 154 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80553494 |
| 155 | detection of biotic stimulus (GO:0009595) | 2.80024814 |
| 156 | response to peptidoglycan (GO:0032494) | 2.79078046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.31198757 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.37123486 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.57539018 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.52996339 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.04993723 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.62107387 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.27185013 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.23079513 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51676245 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30685210 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23751629 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16808121 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.14375861 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.51317587 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47596975 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46041664 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.37853013 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35683434 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35255349 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.34960347 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.21448897 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19197018 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.04649490 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1323311 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.98308495 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89849677 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.89270413 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.89003274 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88445745 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84082545 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83427129 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73460883 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.70527399 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.70271900 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68682219 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52359700 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51038143 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46432406 |
| 39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40159283 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38597008 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38014827 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35591753 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35575524 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34452226 |
| 45 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.33338651 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33300506 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33102373 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32671488 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31627584 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30908343 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30330410 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29429563 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29374441 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29231820 |
| 55 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29126027 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29085813 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27895844 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.27823548 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.25431136 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25423608 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25078502 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24639363 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20916370 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20715327 |
| 65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20567831 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17401333 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15703636 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14467824 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14406332 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13942082 |
| 71 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12183440 |
| 72 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11642216 |
| 73 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.11224887 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.09515482 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09072290 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06722549 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06466724 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05475485 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04954580 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.04851836 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03885764 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03333450 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02896627 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02820935 |
| 85 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02711257 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02648418 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02253538 |
| 88 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.02232588 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00090847 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98548009 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98425605 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98299355 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95596892 |
| 94 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.94281494 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93713565 |
| 96 | MYB_26560356_Chip-Seq_TH2_Human | 0.93112855 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92917459 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92523228 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92323107 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92243249 |
| 101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90601900 |
| 102 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.88197617 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87504515 |
| 104 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84485080 |
| 105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.84255497 |
| 106 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83985989 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 0.83574268 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83316662 |
| 109 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82544270 |
| 110 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82421672 |
| 111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.81444307 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80912375 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80661178 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80584221 |
| 115 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79685896 |
| 116 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79611890 |
| 117 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78359944 |
| 118 | MAF_26560356_Chip-Seq_TH1_Human | 0.77743165 |
| 119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.77239874 |
| 120 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76764070 |
| 121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.76752122 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76432029 |
| 123 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.76129897 |
| 124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.76093614 |
| 125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.75777029 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75245192 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74524821 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73655489 |
| 129 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.73345741 |
| 130 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72795516 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71399574 |
| 132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70684738 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69995392 |
| 134 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.69392311 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.69131091 |
| 136 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.68560741 |
| 137 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.67130933 |
| 138 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67117293 |
| 139 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.66668936 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66444982 |
| 141 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.65687799 |
| 142 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65660826 |
| 143 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.64700111 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64650655 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64006786 |
| 146 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63859580 |
| 147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.63697914 |
| 148 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.62168747 |
| 149 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.62128984 |
| 150 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62070189 |
| 151 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.61830766 |
| 152 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.60945003 |
| 153 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60567705 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.60366669 |
| 155 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.59514081 |
| 156 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.55853133 |
| 157 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.55041486 |
| 158 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.54927936 |
| 159 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.53766616 |
| 160 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.53099930 |
| 161 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52179999 |
| 162 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.48925300 |
| 163 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.48852331 |
| 164 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.48583339 |
| 165 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48474216 |
| 166 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.48239214 |
| 167 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.47999745 |
| 168 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.47495368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.84548120 |
| 2 | MP0005360_urolithiasis | 7.13829917 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.63334342 |
| 4 | MP0005365_abnormal_bile_salt | 5.60307120 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.82115366 |
| 6 | MP0009840_abnormal_foam_cell | 3.99659062 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.67086927 |
| 8 | MP0003252_abnormal_bile_duct | 3.55543184 |
| 9 | MP0005332_abnormal_amino_acid | 3.34792853 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.27594076 |
| 11 | MP0003724_increased_susceptibility_to | 3.12746088 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 3.02713064 |
| 13 | MP0003195_calcinosis | 2.85236700 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.57651745 |
| 15 | MP0005083_abnormal_biliary_tract | 2.48296179 |
| 16 | MP0003436_decreased_susceptibility_to | 2.43025328 |
| 17 | MP0003303_peritoneal_inflammation | 2.27207709 |
| 18 | MP0009785_altered_susceptibility_to | 2.23370948 |
| 19 | MP0005451_abnormal_body_composition | 2.17625991 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.11826898 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.11717736 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.08466595 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.05565027 |
| 24 | MP0000609_abnormal_liver_physiology | 2.03193674 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.96472174 |
| 26 | MP0002419_abnormal_innate_immunity | 1.93000990 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.83868150 |
| 28 | MP0005025_abnormal_response_to | 1.81413322 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.76770107 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.75971046 |
| 31 | * MP0005319_abnormal_enzyme/_coenzyme | 1.74539253 |
| 32 | MP0006082_CNS_inflammation | 1.63909337 |
| 33 | MP0003718_maternal_effect | 1.63422749 |
| 34 | MP0001764_abnormal_homeostasis | 1.58958859 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.55038342 |
| 36 | MP0003186_abnormal_redox_activity | 1.54108591 |
| 37 | MP0001756_abnormal_urination | 1.50046226 |
| 38 | MP0005387_immune_system_phenotype | 1.49280025 |
| 39 | MP0001790_abnormal_immune_system | 1.49280025 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.47739471 |
| 41 | MP0001800_abnormal_humoral_immune | 1.47406371 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.42958955 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.40761105 |
| 44 | MP0000685_abnormal_immune_system | 1.39756583 |
| 45 | MP0001661_extended_life_span | 1.38829384 |
| 46 | MP0002723_abnormal_immune_serum | 1.33349124 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32584842 |
| 48 | MP0003868_abnormal_feces_composition | 1.32199655 |
| 49 | MP0005636_abnormal_mineral_homeostasis | 1.28874227 |
| 50 | MP0005671_abnormal_response_to | 1.28501410 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.28265863 |
| 52 | MP0005166_decreased_susceptibility_to | 1.26766705 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.17731075 |
| 54 | MP0000598_abnormal_liver_morphology | 1.17062808 |
| 55 | MP0003075_altered_response_to | 1.14957806 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.13888807 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.12765562 |
| 58 | MP0003866_abnormal_defecation | 1.10990958 |
| 59 | MP0001819_abnormal_immune_cell | 1.10214055 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.09247947 |
| 61 | MP0009697_abnormal_copulation | 1.07652140 |
| 62 | MP0005395_other_phenotype | 1.05594060 |
| 63 | MP0002136_abnormal_kidney_physiology | 1.05254374 |
| 64 | MP0008260_abnormal_autophagy | 1.04399408 |
| 65 | MP0008004_abnormal_stomach_pH | 1.02932015 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.02490147 |
| 67 | MP0005164_abnormal_response_to | 1.01156857 |
| 68 | MP0000604_amyloidosis | 1.00903831 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.00539628 |
| 70 | MP0004043_abnormal_pH_regulation | 0.98405066 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 0.96192954 |
| 72 | MP0004947_skin_inflammation | 0.96162974 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 0.93673243 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.93262232 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.91347239 |
| 76 | MP0005670_abnormal_white_adipose | 0.91192879 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 0.89542718 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.89542718 |
| 79 | MP0005408_hypopigmentation | 0.89206711 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.88451127 |
| 81 | MP0000343_altered_response_to | 0.87494005 |
| 82 | MP0009053_abnormal_anal_canal | 0.87187369 |
| 83 | MP0003011_delayed_dark_adaptation | 0.86819329 |
| 84 | MP0003329_amyloid_beta_deposits | 0.86209614 |
| 85 | MP0000858_altered_metastatic_potential | 0.86195422 |
| 86 | MP0005647_abnormal_sex_gland | 0.85898739 |
| 87 | MP0001663_abnormal_digestive_system | 0.85840601 |
| 88 | MP0002405_respiratory_system_inflammati | 0.85825198 |
| 89 | MP0009764_decreased_sensitivity_to | 0.85713141 |
| 90 | MP0000249_abnormal_blood_vessel | 0.85352759 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.83872549 |
| 92 | MP0003878_abnormal_ear_physiology | 0.81765224 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.81765224 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.80189786 |
| 95 | MP0000716_abnormal_immune_system | 0.79492706 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.78524946 |
| 97 | MP0008469_abnormal_protein_level | 0.78088729 |
| 98 | MP0003828_pulmonary_edema | 0.77731305 |
| 99 | MP0001542_abnormal_bone_strength | 0.73063300 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.71009553 |
| 101 | MP0002254_reproductive_system_inflammat | 0.70925222 |
| 102 | MP0009763_increased_sensitivity_to | 0.70214716 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.69417241 |
| 104 | MP0008874_decreased_physiological_sensi | 0.68450105 |
| 105 | MP0004510_myositis | 0.68296629 |
| 106 | MP0001851_eye_inflammation | 0.67361868 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.66881541 |
| 108 | MP0003879_abnormal_hair_cell | 0.66019199 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.64184637 |
| 110 | MP0003763_abnormal_thymus_physiology | 0.64033608 |
| 111 | MP0002796_impaired_skin_barrier | 0.63671697 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.63400861 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.63394249 |
| 114 | MP0001765_abnormal_ion_homeostasis | 0.63181312 |
| 115 | MP0002398_abnormal_bone_marrow | 0.62804988 |
| 116 | MP0003693_abnormal_embryo_hatching | 0.61883989 |
| 117 | MP0001873_stomach_inflammation | 0.60078780 |
| 118 | MP0009384_cardiac_valve_regurgitation | 0.59169047 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.57782838 |
| 120 | MP0010368_abnormal_lymphatic_system | 0.55492972 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.54677586 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.53918663 |
| 123 | MP0002971_abnormal_brown_adipose | 0.52794576 |
| 124 | MP0010234_abnormal_vibrissa_follicle | 0.51234191 |
| 125 | MP0002168_other_aberrant_phenotype | 0.50855144 |
| 126 | MP0009672_abnormal_birth_weight | 0.50783553 |
| 127 | MP0005334_abnormal_fat_pad | 0.50246735 |
| 128 | MP0001958_emphysema | 0.46382014 |
| 129 | MP0005266_abnormal_metabolism | 0.46377330 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.44394833 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.42558045 |
| 132 | MP0005535_abnormal_body_temperature | 0.41540972 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.40568623 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.39997306 |
| 135 | MP0005023_abnormal_wound_healing | 0.38006852 |
| 136 | MP0003953_abnormal_hormone_level | 0.37168208 |
| 137 | MP0004883_abnormal_blood_vessel | 0.36209281 |
| 138 | MP0003690_abnormal_glial_cell | 0.35089168 |
| 139 | MP0005275_abnormal_skin_tensile | 0.34657299 |
| 140 | MP0004147_increased_porphyrin_level | 0.34185583 |
| 141 | MP0009115_abnormal_fat_cell | 0.33380719 |
| 142 | MP0003300_gastrointestinal_ulcer | 0.32313119 |
| 143 | MP0004130_abnormal_muscle_cell | 0.32193873 |
| 144 | MP0002269_muscular_atrophy | 0.31347381 |
| 145 | MP0001881_abnormal_mammary_gland | 0.31301224 |
| 146 | MP0002060_abnormal_skin_morphology | 0.31135770 |
| 147 | MP0005448_abnormal_energy_balance | 0.30665256 |
| 148 | MP0005330_cardiomyopathy | 0.30507499 |
| 149 | MP0002132_abnormal_respiratory_system | 0.28884149 |
| 150 | MP0000639_abnormal_adrenal_gland | 0.28608199 |
| 151 | MP0008873_increased_physiological_sensi | 0.28539837 |
| 152 | MP0002928_abnormal_bile_duct | 0.27189151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.02773720 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 5.74014181 |
| 3 | Xanthomatosis (HP:0000991) | 5.67149225 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.66322234 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.65344155 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.61520452 |
| 7 | Hyperglycinuria (HP:0003108) | 5.61272037 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.58770895 |
| 9 | Hyperglycinemia (HP:0002154) | 5.38732748 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.12525624 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 5.12525624 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.99237412 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.95351305 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.95143010 |
| 15 | Gout (HP:0001997) | 4.69556092 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.61087855 |
| 17 | Hyperammonemia (HP:0001987) | 4.44425096 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.32899240 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10661389 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04815999 |
| 21 | Gingival bleeding (HP:0000225) | 4.02319345 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.90472202 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.89211080 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.87486815 |
| 25 | Ketosis (HP:0001946) | 3.84878968 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.73537645 |
| 27 | Abnormality of serum amino acid levels (HP:0003112) | 3.69823370 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.61950940 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.52738019 |
| 30 | Purpura (HP:0000979) | 3.51744120 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.50946022 |
| 32 | Epidermoid cyst (HP:0200040) | 3.49359172 |
| 33 | Fat malabsorption (HP:0002630) | 3.43291967 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.42242127 |
| 35 | Orchitis (HP:0100796) | 3.36305066 |
| 36 | Nephritis (HP:0000123) | 3.34584814 |
| 37 | Complement deficiency (HP:0004431) | 3.34047455 |
| 38 | Joint hemorrhage (HP:0005261) | 3.31886436 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28155668 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.28077447 |
| 41 | Recurrent abscess formation (HP:0002722) | 3.25258671 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.24834337 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24441985 |
| 44 | Abnormality of macrophages (HP:0004311) | 3.23720038 |
| 45 | Myositis (HP:0100614) | 3.21045927 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.17816039 |
| 47 | Hyperuricemia (HP:0002149) | 3.16913915 |
| 48 | Increased purine levels (HP:0004368) | 3.16913915 |
| 49 | Optic neuritis (HP:0100653) | 3.14496989 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 3.14496989 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.14108965 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 3.14108965 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09752589 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 3.08278044 |
| 55 | Recurrent bacterial skin infections (HP:0005406) | 2.96305481 |
| 56 | Ketoacidosis (HP:0001993) | 2.95734080 |
| 57 | Epistaxis (HP:0000421) | 2.94836735 |
| 58 | Lethargy (HP:0001254) | 2.94256669 |
| 59 | Amyloidosis (HP:0011034) | 2.92231312 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.89294384 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.86706904 |
| 62 | Metabolic acidosis (HP:0001942) | 2.84466616 |
| 63 | Pulmonary embolism (HP:0002204) | 2.84407228 |
| 64 | Malnutrition (HP:0004395) | 2.78485468 |
| 65 | Menorrhagia (HP:0000132) | 2.74370790 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.74065314 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.74065314 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.69741189 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.69361521 |
| 70 | Irritability (HP:0000737) | 2.62158652 |
| 71 | Generalized aminoaciduria (HP:0002909) | 2.58279660 |
| 72 | Petechiae (HP:0000967) | 2.57837741 |
| 73 | Abnormal platelet volume (HP:0011876) | 2.57746470 |
| 74 | Glycosuria (HP:0003076) | 2.57340984 |
| 75 | Abnormality of urine glucose concentration (HP:0011016) | 2.57340984 |
| 76 | Abnormal cartilage morphology (HP:0002763) | 2.56372153 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.55124539 |
| 78 | Vascular calcification (HP:0004934) | 2.54934208 |
| 79 | Gangrene (HP:0100758) | 2.54539087 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51376854 |
| 81 | Obstructive lung disease (HP:0006536) | 2.51376854 |
| 82 | Gingivitis (HP:0000230) | 2.50892998 |
| 83 | Steatorrhea (HP:0002570) | 2.50536692 |
| 84 | Joint swelling (HP:0001386) | 2.49619283 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.47960638 |
| 86 | Thrombophlebitis (HP:0004418) | 2.47195655 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.46191392 |
| 88 | Increased serum ferritin (HP:0003281) | 2.41691077 |
| 89 | Nausea (HP:0002018) | 2.39349521 |
| 90 | Abnormality of complement system (HP:0005339) | 2.38372633 |
| 91 | Increased mean platelet volume (HP:0011877) | 2.38223012 |
| 92 | Alkalosis (HP:0001948) | 2.34312975 |
| 93 | Megaloblastic anemia (HP:0001889) | 2.33260503 |
| 94 | Anorexia (HP:0002039) | 2.31590663 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.30092570 |
| 96 | Stomatitis (HP:0010280) | 2.29461083 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.29330214 |
| 98 | Vasculitis (HP:0002633) | 2.28664746 |
| 99 | Spastic diplegia (HP:0001264) | 2.27899078 |
| 100 | Meningitis (HP:0001287) | 2.27650806 |
| 101 | Myocardial infarction (HP:0001658) | 2.26968495 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 2.25928202 |
| 103 | Spontaneous abortion (HP:0005268) | 2.25681098 |
| 104 | Hyperglycemia (HP:0003074) | 2.25481905 |
| 105 | Brushfield spots (HP:0001088) | 2.24672365 |
| 106 | Osteomalacia (HP:0002749) | 2.21938859 |
| 107 | Encephalitis (HP:0002383) | 2.21515602 |
| 108 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.17552944 |
| 109 | Acanthocytosis (HP:0001927) | 2.15933910 |
| 110 | Skin nodule (HP:0200036) | 2.15865820 |
| 111 | Global brain atrophy (HP:0002283) | 2.13890697 |
| 112 | Vomiting (HP:0002013) | 2.12651901 |
| 113 | Ileus (HP:0002595) | 2.08425863 |
| 114 | Arterial thrombosis (HP:0004420) | 2.08367890 |
| 115 | Hemoptysis (HP:0002105) | 2.08359313 |
| 116 | Esophageal varix (HP:0002040) | 2.07112306 |
| 117 | Recurrent skin infections (HP:0001581) | 2.05962812 |
| 118 | Glomerulonephritis (HP:0000099) | 2.05338621 |
| 119 | Keratoconjunctivitis (HP:0001096) | 2.05094456 |
| 120 | Widely patent fontanelles and sutures (HP:0004492) | 2.04789873 |
| 121 | Poikilocytosis (HP:0004447) | 2.02935125 |
| 122 | Hypochromic microcytic anemia (HP:0004840) | 1.99021795 |
| 123 | Abnormal platelet function (HP:0011869) | 1.98607283 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.98607283 |
| 125 | Rickets (HP:0002748) | 1.98027554 |
| 126 | Mediastinal lymphadenopathy (HP:0100721) | 1.96934649 |
| 127 | Confusion (HP:0001289) | 1.96166027 |
| 128 | Urticaria (HP:0001025) | 1.95968229 |
| 129 | Pulmonary infiltrates (HP:0002113) | 1.94645239 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94376258 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93260722 |
| 132 | Elevated alkaline phosphatase (HP:0003155) | 1.92114011 |
| 133 | Sensorimotor neuropathy (HP:0007141) | 1.92031300 |
| 134 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.91749997 |
| 135 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.91749997 |
| 136 | Abnormality of glycolipid metabolism (HP:0010969) | 1.91749997 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91155865 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.91155865 |
| 139 | Pancreatitis (HP:0001733) | 1.90144507 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89360729 |
| 141 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89360729 |
| 142 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89360729 |
| 143 | Peritonitis (HP:0002586) | 1.89118894 |
| 144 | Hypophosphatemia (HP:0002148) | 1.89032013 |
| 145 | Tetraplegia (HP:0002445) | 1.85128822 |
| 146 | Abnormality of vitamin metabolism (HP:0100508) | 1.83906099 |
| 147 | Spastic paraparesis (HP:0002313) | 1.82967267 |
| 148 | Methylmalonic aciduria (HP:0012120) | 1.82826022 |
| 149 | Nephrolithiasis (HP:0000787) | 1.82207833 |
| 150 | Enlarged kidneys (HP:0000105) | 1.81206748 |
| 151 | Cerebral edema (HP:0002181) | 1.80742876 |
| 152 | Opisthotonus (HP:0002179) | 1.79065748 |
| 153 | Hypokalemic alkalosis (HP:0001949) | 1.79036393 |
| 154 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74579243 |
| 155 | Neonatal onset (HP:0003623) | 1.74294213 |
| 156 | Polycythemia (HP:0001901) | 1.73860216 |
| 157 | Renal cortical cysts (HP:0000803) | 1.72218631 |
| 158 | Atrioventricular block (HP:0001678) | 1.71396888 |
| 159 | Hypoglycemic seizures (HP:0002173) | 1.70707317 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.70472128 |
| 161 | Alopecia of scalp (HP:0002293) | 1.70253219 |
| 162 | Mitral stenosis (HP:0001718) | 1.69909774 |
| 163 | Multiple enchondromatosis (HP:0005701) | 1.67222148 |
| 164 | CNS demyelination (HP:0007305) | 1.67070499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.50172767 |
| 2 | AKT3 | 4.30527279 |
| 3 | EPHA2 | 4.19990049 |
| 4 | BUB1 | 4.01172650 |
| 5 | RIPK4 | 3.86747102 |
| 6 | LMTK2 | 3.25458166 |
| 7 | WEE1 | 2.55923394 |
| 8 | WNK3 | 2.43298918 |
| 9 | PDK4 | 2.39358014 |
| 10 | PDK3 | 2.39358014 |
| 11 | FGFR4 | 2.38091799 |
| 12 | BLK | 2.34000377 |
| 13 | PINK1 | 2.21335469 |
| 14 | CSK | 2.11856202 |
| 15 | STK38L | 2.07724909 |
| 16 | IRAK4 | 2.07678591 |
| 17 | MAP3K14 | 2.06324690 |
| 18 | SIK1 | 2.03157204 |
| 19 | MAP4K1 | 2.01928671 |
| 20 | PLK4 | 2.00077964 |
| 21 | MST1R | 1.98199720 |
| 22 | ACVR1B | 1.92576364 |
| 23 | ZAP70 | 1.92240515 |
| 24 | ERN1 | 1.83365674 |
| 25 | PDK2 | 1.82716751 |
| 26 | IRAK3 | 1.80992013 |
| 27 | FRK | 1.70441680 |
| 28 | PRKG2 | 1.67657628 |
| 29 | EPHB1 | 1.67414513 |
| 30 | NEK1 | 1.61999181 |
| 31 | TSSK6 | 1.60919487 |
| 32 | MAP3K2 | 1.55544683 |
| 33 | MATK | 1.54260102 |
| 34 | EIF2AK1 | 1.51616536 |
| 35 | PRPF4B | 1.51103694 |
| 36 | STK16 | 1.49783222 |
| 37 | LATS1 | 1.48862011 |
| 38 | WNK4 | 1.48658047 |
| 39 | TAOK1 | 1.48118059 |
| 40 | SYK | 1.46506354 |
| 41 | FES | 1.43983375 |
| 42 | TNK2 | 1.42640540 |
| 43 | FGR | 1.42189617 |
| 44 | MAP3K1 | 1.41625289 |
| 45 | JAK3 | 1.41359138 |
| 46 | TRIB3 | 1.41321809 |
| 47 | JAK1 | 1.39577151 |
| 48 | PKN2 | 1.39538473 |
| 49 | BMPR2 | 1.39251371 |
| 50 | BTK | 1.38374282 |
| 51 | MAP3K12 | 1.36822566 |
| 52 | ZAK | 1.35941208 |
| 53 | MAP3K3 | 1.33438212 |
| 54 | CSF1R | 1.32471272 |
| 55 | OXSR1 | 1.31802371 |
| 56 | MAP3K13 | 1.31075440 |
| 57 | IKBKE | 1.31007364 |
| 58 | IRAK1 | 1.30516306 |
| 59 | EPHA3 | 1.26561019 |
| 60 | NEK2 | 1.21872869 |
| 61 | HCK | 1.19556235 |
| 62 | ABL2 | 1.17189300 |
| 63 | NEK9 | 1.16879668 |
| 64 | TXK | 1.15654087 |
| 65 | BRSK2 | 1.13627907 |
| 66 | STK3 | 1.12886834 |
| 67 | LYN | 1.12510824 |
| 68 | IKBKB | 1.09416809 |
| 69 | TTK | 1.06839755 |
| 70 | ERBB4 | 1.05726804 |
| 71 | TAOK2 | 1.04428257 |
| 72 | TAOK3 | 1.01431087 |
| 73 | PDK1 | 1.00745952 |
| 74 | FGFR3 | 1.00153483 |
| 75 | NME2 | 0.99921012 |
| 76 | TGFBR2 | 0.99621245 |
| 77 | MAP3K6 | 0.98637757 |
| 78 | KDR | 0.97986655 |
| 79 | PIK3CG | 0.97764280 |
| 80 | TEC | 0.95261769 |
| 81 | PTK6 | 0.94199285 |
| 82 | ARAF | 0.94113005 |
| 83 | YES1 | 0.91403370 |
| 84 | MAPK11 | 0.89728315 |
| 85 | MAP3K5 | 0.88703528 |
| 86 | KIT | 0.86669100 |
| 87 | NLK | 0.86343359 |
| 88 | SIK3 | 0.81716290 |
| 89 | LCK | 0.81591080 |
| 90 | INSRR | 0.81309089 |
| 91 | PIK3CA | 0.78738942 |
| 92 | FLT3 | 0.75822029 |
| 93 | ITK | 0.75003441 |
| 94 | MET | 0.74164724 |
| 95 | KSR2 | 0.74120367 |
| 96 | MAP2K2 | 0.71628290 |
| 97 | LATS2 | 0.70311785 |
| 98 | MAP3K11 | 0.66741479 |
| 99 | TYK2 | 0.66730614 |
| 100 | MAP2K6 | 0.65085086 |
| 101 | CDC42BPA | 0.64577115 |
| 102 | MARK3 | 0.64111767 |
| 103 | EIF2AK3 | 0.63351488 |
| 104 | PRKCZ | 0.62263270 |
| 105 | PTK2 | 0.61769452 |
| 106 | MAP3K8 | 0.61602135 |
| 107 | PRKAA1 | 0.61323949 |
| 108 | STK24 | 0.61045648 |
| 109 | PRKAA2 | 0.61029033 |
| 110 | ERBB2 | 0.59735971 |
| 111 | PRKCI | 0.59589630 |
| 112 | GRK7 | 0.58658955 |
| 113 | CSNK1G1 | 0.58317142 |
| 114 | BRAF | 0.58044562 |
| 115 | FYN | 0.57439711 |
| 116 | LRRK2 | 0.57110070 |
| 117 | GSK3A | 0.55978473 |
| 118 | NUAK1 | 0.55304854 |
| 119 | MYLK | 0.54971894 |
| 120 | MAP3K7 | 0.54184440 |
| 121 | CAMK2G | 0.53985373 |
| 122 | MAP2K1 | 0.53478072 |
| 123 | PLK1 | 0.52389484 |
| 124 | BRSK1 | 0.51885226 |
| 125 | IRAK2 | 0.51803445 |
| 126 | TESK2 | 0.51407762 |
| 127 | CDK6 | 0.51012342 |
| 128 | CAMKK2 | 0.50639525 |
| 129 | MAP2K4 | 0.50207058 |
| 130 | PRKCQ | 0.50154247 |
| 131 | PDPK1 | 0.48337492 |
| 132 | MAPK7 | 0.48220763 |
| 133 | PLK3 | 0.45434038 |
| 134 | PAK4 | 0.45131897 |
| 135 | GRK6 | 0.44722384 |
| 136 | AURKB | 0.44550480 |
| 137 | BMX | 0.44033769 |
| 138 | CSNK1G3 | 0.43665315 |
| 139 | RET | 0.43651688 |
| 140 | FER | 0.43246474 |
| 141 | CDK4 | 0.43037503 |
| 142 | IGF1R | 0.42793308 |
| 143 | MTOR | 0.42041325 |
| 144 | MAPK4 | 0.42002502 |
| 145 | GRK1 | 0.41991920 |
| 146 | PIM2 | 0.41542603 |
| 147 | STK38 | 0.39831359 |
| 148 | PTK2B | 0.39365248 |
| 149 | PRKACG | 0.39187195 |
| 150 | DYRK1B | 0.39101327 |
| 151 | PRKCD | 0.39038241 |
| 152 | AURKA | 0.37854378 |
| 153 | MAP2K3 | 0.37821327 |
| 154 | PAK3 | 0.36391034 |
| 155 | JAK2 | 0.34452944 |
| 156 | DYRK3 | 0.33553029 |
| 157 | PIM1 | 0.33320233 |
| 158 | MAPK12 | 0.33135574 |
| 159 | TIE1 | 0.32827062 |
| 160 | STK10 | 0.32826292 |
| 161 | PRKCG | 0.31560735 |
| 162 | ABL1 | 0.30650197 |
| 163 | PNCK | 0.30118298 |
| 164 | CSNK1A1L | 0.29411283 |
| 165 | SGK3 | 0.28893973 |
| 166 | RIPK1 | 0.28678296 |
| 167 | DAPK2 | 0.27500746 |
| 168 | CSNK1E | 0.26292131 |
| 169 | TBK1 | 0.24978345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56075925 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22590014 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.85339187 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.76050606 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71958218 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71374734 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66756447 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57547978 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56780417 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46175154 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43951371 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42577539 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40403433 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.13430752 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.09527612 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.09426094 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07189680 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97687466 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94732003 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93262565 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93125227 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90354965 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89504954 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89136910 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88119500 |
| 26 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.79855531 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.79293192 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74207493 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72650192 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68896422 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.65854023 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61109429 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56247497 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50379438 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.47802940 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46943652 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44440966 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.41457184 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40026803 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38955158 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38671299 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36117144 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32398830 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31068479 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29769443 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27370619 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23712720 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20970087 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16396209 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16279893 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14602358 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06000179 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05196478 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04505476 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.01302960 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01286867 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99385537 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94960871 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.94704261 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92606922 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91459201 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.91454546 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91098809 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89293504 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88393314 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84868224 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79631877 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78937554 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.75970239 |
| 70 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75835405 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75549744 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.75494483 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74814857 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73827805 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72362690 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69769638 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.68798303 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66077034 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65938858 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65362076 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.62334046 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61802874 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61307569 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59507983 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56418257 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55782847 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.55743018 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55134998 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50432255 |
| 90 | Proteasome_Homo sapiens_hsa03050 | 0.50391932 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50208739 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48235319 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46213231 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46082996 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44868552 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44300708 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.44000331 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43669365 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42513328 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41769345 |
| 101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40002582 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.39017343 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.37867178 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36500757 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35835648 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34310783 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34043468 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | 0.33547175 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32808392 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.32146197 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31389267 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.28108092 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27768365 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.26381997 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25579501 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.25132320 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22458549 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.20952100 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18252206 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14931103 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.06815532 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.05612787 |
| 123 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.05425133 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.05121481 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01907713 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.01783608 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1937306 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1884297 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1763428 |
| 130 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1564050 |
| 131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1515463 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1400569 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1384226 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1377264 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0515549 |
| 136 | RNA polymerase_Homo sapiens_hsa03020 | -0.0325367 |
| 137 | Purine metabolism_Homo sapiens_hsa00230 | -0.0309939 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0256020 |

